2.72
price down icon2.51%   -0.07
pre-market  Pre-market:  2.67   -0.05   -1.84%
loading
Aerovate Therapeutics Inc stock is traded at $2.72, with a volume of 666.34K. It is down -2.51% in the last 24 hours and up +32.68% over the past month. Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.
See More
Previous Close:
$2.79
Open:
$2.79
24h Volume:
666.34K
Relative Volume:
0.90
Market Cap:
$78.23M
Revenue:
-
Net Income/Loss:
$-75.52M
P/E Ratio:
-1.0462
EPS:
-2.6
Net Cash Flow:
$-56.92M
1W Performance:
+24.77%
1M Performance:
+32.68%
6M Performance:
-86.59%
1Y Performance:
-76.29%
1-Day Range:
Value
$2.64
$2.81
1-Week Range:
Value
$2.17
$3.00
52-Week Range:
Value
$1.25
$32.41

Aerovate Therapeutics Inc Stock (AVTE) Company Profile

Name
Name
Aerovate Therapeutics Inc
Name
Phone
617-443-2400
Name
Address
930 WINTER STREET, WALTHAM
Name
Employee
51
Name
Twitter
Name
Next Earnings Date
2024-08-12
Name
Latest SEC Filings
Name
AVTE's Discussions on Twitter

Aerovate Therapeutics Inc Stock (AVTE) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-01-23 Initiated Guggenheim Buy
Dec-06-22 Upgrade BTIG Research Neutral → Buy
Sep-19-22 Resumed Wedbush Outperform
Aug-16-22 Downgrade BTIG Research Buy → Neutral
Feb-11-22 Initiated BTIG Research Buy
Jul-26-21 Initiated Cowen Outperform
Jul-26-21 Initiated Evercore ISI Outperform
Jul-26-21 Initiated Jefferies Buy
Jul-26-21 Initiated Wedbush Outperform
View All

Aerovate Therapeutics Inc Stock (AVTE) Latest News

pulisher
Nov 04, 2024

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Air Transport Services Group, Inc. (Nasdaq– ATSG), Micropac Industries, Inc. (OTC – MPAD), Aerovate Therapeutics, Inc. (Nasdaq – AVTE), Outbrain Inc. (Nasd - ForexTV.com

Nov 04, 2024
pulisher
Nov 04, 2024

AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc.AVTE - Marketscreener.com

Nov 04, 2024
pulisher
Nov 04, 2024

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Nov 04, 2024
pulisher
Nov 03, 2024

INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc.AVTE - PR Newswire

Nov 03, 2024
pulisher
Nov 02, 2024

Aerovate Therapeutics Enters into Merger Agreement with Jade Biosciences - Defense World

Nov 02, 2024
pulisher
Nov 01, 2024

How Fairmount’s Paragon incubator steered two more companies to NASDAQ - BioCentury

Nov 01, 2024
pulisher
Nov 01, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE and PFIE on Behalf of Shareholders - Marketscreener.com

Nov 01, 2024
pulisher
Nov 01, 2024

Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm - The Malaysian Reserve

Nov 01, 2024
pulisher
Nov 01, 2024

Finansavisen - Finansavisen

Nov 01, 2024
pulisher
Oct 31, 2024

SEC Form 425 filed by Aerovate Therapeutics Inc. - Quantisnow

Oct 31, 2024
pulisher
Oct 31, 2024

Aerovate (AVTE) Shares Rally As Market Responds To A Merger Agreement - Stocks Telegraph

Oct 31, 2024
pulisher
Oct 31, 2024

Jade, another biotech spinout of Paragon, to merge with Aerovate - BioPharma Dive

Oct 31, 2024
pulisher
Oct 31, 2024

Jade Biosciences and Aerovate announce merger deal - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders - Business Wire

Oct 31, 2024
pulisher
Oct 31, 2024

Aerovate to Merge With Jade Biosciences, Pursue Kidney Treatment - MarketWatch

Oct 31, 2024
pulisher
Oct 31, 2024

Shareholder Alert: Ademi LLP Investigates Whether Aerovate Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire

Oct 31, 2024
pulisher
Oct 31, 2024

Aerovate climbs on all-stock merger deal with Jade - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Aerovate stock rises on all-stock merger deal (AVTE:NASDAQ) - Seeking Alpha

Oct 31, 2024
pulisher
Oct 31, 2024

Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement - GlobeNewswire

Oct 31, 2024
pulisher
Oct 28, 2024

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Down 21.4% in October - MarketBeat

Oct 28, 2024
pulisher
Oct 17, 2024

Aerovate Therapeutics regains Nasdaq compliance - Investing.com India

Oct 17, 2024
pulisher
Oct 17, 2024

Aerovate Therapeutics regains Nasdaq compliance By Investing.com - Investing.com Canada

Oct 17, 2024
pulisher
Oct 17, 2024

Hypertension Clinical Trials 2024: FDA Approvals, Medication, Therapies, MOA, ROA, Companies by DelveInsight | Quantum Genomics, CinCor Pharma, Mineralys Therapeutics, Alnylam Therapeutics, Novartis - The Globe and Mail

Oct 17, 2024
pulisher
Oct 17, 2024

Cubist Systematic Strategies LLC Makes New Investment in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Oct 17, 2024
pulisher
Oct 17, 2024

Cubist Systematic Strategies LLC Grows Holdings in Omega Therapeutics, Inc. (NASDAQ:OMGA) - Defense World

Oct 17, 2024
pulisher
Oct 14, 2024

Analyzing Aerovate Therapeutics Inc (AVTE) After Recent Trading Activity - Knox Daily

Oct 14, 2024
pulisher
Oct 13, 2024

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Update - MarketBeat

Oct 13, 2024
pulisher
Oct 10, 2024

Aerovate Therapeutics announces board member resignation - Investing.com India

Oct 10, 2024
pulisher
Oct 10, 2024

Aerovate Therapeutics announces board member resignation By Investing.com - Investing.com UK

Oct 10, 2024
pulisher
Oct 03, 2024

XTX Topco Ltd Invests $35,000 in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Oct 03, 2024
pulisher
Sep 28, 2024

Short Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Decreases By 15.7% - MarketBeat

Sep 28, 2024
pulisher
Sep 28, 2024

Bank of New York Mellon Corp Increases Stake in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Sep 28, 2024
pulisher
Sep 26, 2024

Deerfield Management Company L.P. Series C Takes Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Sep 26, 2024
pulisher
Sep 26, 2024

Deerfield Management Company L.P. Series C Acquires New Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat

Sep 26, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Makes New $332,000 Investment in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Sep 25, 2024
pulisher
Sep 24, 2024

Market Highlights: Alector Inc (ALEC) Ends on a Low Note at 5.45 - The Dwinnex

Sep 24, 2024
pulisher
Sep 24, 2024

AlgoTx completes pivotal phase 2 trial for ground-breaking CIPN treatment - PharmaTimes

Sep 24, 2024
pulisher
Sep 23, 2024

Why AeroVironment Shares Are Flying Higher Today - sharewise

Sep 23, 2024
pulisher
Sep 23, 2024

Alector (NASDAQ:ALEC) Shares Down 5.6% - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Defense Stock Soars on ‘Rare Move’ From the U.S. Army - Barron's

Sep 23, 2024
pulisher
Sep 23, 2024

AeroVironment (NASDAQ:AVAV) Shares Gap Up to $182.76 - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

AeroVironment Stock Is Rising Monday: What's Driving The Action? - Benzinga

Sep 23, 2024
pulisher
Sep 23, 2024

Altitude Group’s AGM: Mixed Shareholder Decisions - TipRanks

Sep 23, 2024
pulisher
Sep 23, 2024

AeroVironment Inc. (AVAV): Why Are Short Sellers Betting Against This Defense Tech Leader? - Insider Monkey

Sep 23, 2024
pulisher
Sep 23, 2024

Recent Insider Activity Suggests Potential Gains for Aerovate Therapeutics Inc (AVTE) - Knox Daily

Sep 23, 2024
pulisher
Sep 21, 2024

Alector (NASDAQ:ALEC) Stock Price Up 9% - Defense World

Sep 21, 2024
pulisher
Sep 19, 2024

Quest Partners LLC Increases Stock Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Alector, Inc. (NASDAQ:ALEC) Short Interest Down 5.7% in August - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

Allurion Technologies Inc. (NYSE:ALUR) Short Interest Up 8.6% in August - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Alignment healthcare CEO sells shares worth over $1m - Investing.com

Sep 18, 2024
pulisher
Sep 18, 2024

In the Green: Alector Inc (ALEC) Closes at 5.64, Up/Down -0.70 from Previous Day - The Dwinnex

Sep 18, 2024

Aerovate Therapeutics Inc Stock (AVTE) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$19.96
price up icon 5.11%
$75.75
price down icon 0.50%
$376.80
price up icon 0.74%
$53.54
price down icon 2.00%
$207.25
price up icon 1.49%
$108.97
price down icon 2.25%
Cap:     |  Volume (24h):